This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Our aim was to assess the impact on paediatric congenitalheartdisease (CHD) procedures during different pandemic periods compared with the prepandemic period, to inform appropriate responses to future major health services disruptions.
Background While research on congenitalheartdisease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenitalheartdisease in the Arab world from 1997 to 2022.
Objective To evaluate for correlation between exercise capacity as assessed by peak oxygen consumption (pVO 2 ) measurement during a cardiopulmonary exercise test (CPET) and smartwatches reporting this parameter in patients with adult congenitalheartdisease (ACHD) complex lesions.
Introduction:Fontan surgery performed during childhood enhances the lifespan and quality of life of patients with critical congenitalheartdisease. Stroke, Volume 55, Issue Suppl_1 , Page AWMP70-AWMP70, February 1, 2024.
Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrial fibrillation (AF) and atrial flutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenitalheartdisease (CHD). The unit of analysis was each episode of AF/IART.
Journal of the American Heart Association, Ahead of Print. BackgroundTransgender and gender diverse (TGD) individuals and long‐term survivors with adult congenitalheartdisease (ACHD) are both growing populations with specialized needs.
Journal of the American Heart Association, Ahead of Print. BackgroundFontan circulation (FC) in complex congenitalheartdisease is characterized by altered hemodynamics and associated with Fontanassociated liver disease. Patients with FC may exhibit abnormalities in cholate clearance due to abnormal perfusion.
Webinar New STAT Scores, New Patients, New CHSD: The Upgrade Webinar kchalko Tue, 03/08/2022 - 12:49 March 17, 2022 The CongenitalHeart Surgery Database (CHSD) continues to undergo improvements to enhance quality of care for patients. and implementation of new STAT scores. and implementation of new STAT scores.
In early 2022, the ABIM updated its fee structure to help physicians pay less over time to maintain their certifications. The Cardiology MOC exam covers the following subjects : Arrhythmias 15% Coronary Artery Disease 21.5% Here are some common questions surrounding the Cardiology MOC Exam: When is the Cardiology MOC exam offered?
BACKGROUND:Maldistribution of pulmonary blood flow in patients with congenitalheartdisease impacts exertional performance and pulmonary artery growth. Circulation: Cardiovascular Interventions, Ahead of Print. Currently, measurement of relative pulmonary perfusion can only be performed outside the catheterization laboratory.
Introduction:Adults with congenitalheartdisease (ACHD) are at risk for stroke, but risk factors within this population are not well characterized.Methods:We reviewed medical records of patients evaluated in an ACHD clinic from 8/1/1995- 3/1/2022 who underwent brain imaging for any reason.
Introduction:The number of adults with congenitalheartdiseases (CHD) is rapidly increasing, who are frequently associated with cardiovascular morbidities and may result in poor outcomes. Circulation, Volume 150, Issue Suppl_1 , Page A4140019-A4140019, November 12, 2024.
The incidence of babies born with serious heart defects, known as cyanotic congenitalheartdisease (CCHD), rose in states that enacted restrictive abortion laws following the U.S.
Supreme Courts 2022 Dobbs v. Jackson Womens Health Organization decision have a higher incidence of babies born with cyanotic congenitalheartdisease (CCHD), States with more restrictive abortion laws following the U.S.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
References Law YM, Lal AK, Chen S, Čiháková D, Cooper LT Jr, Deshpande S, Godown J, Grosse-Wortmann L, Robinson JD, Towbin JA; American Heart Association Pediatric Heart Failure and Transplantation Committee of the Council on Lifelong CongenitalHeartDisease and Heart Health in the Young and Stroke Council.
Background Studies predating widespread COVID-19 vaccination identified patients with congenitalheartdisease (CHD) as a group at increased risk of severe outcomes from COVID-19. Here we evaluate the impact of vaccination on COVID-19 outcomes among patients with CHD.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content